2016 ATVB Plenary Lecture
Open Access
- 1 April 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 37 (4) , 613-621
Abstract
The receptor for advanced glycation endproducts (RAGE) interacts with a unique repertoire of ligands that form and collect in the tissues and circulation in diabetes mellitus, aging, inflammation, renal failure, and obesity. RAGE is expressed on multiple cell types linked to tissue perturbation in these settings. This brief review focuses on the role of RAGE in monocytes/macrophages and how RAGE ligand engagement on these cells mediates seminal changes in monocyte/macrophage migration, oxidative stress, cholesterol efflux, and pro- versus anti-inflammatory cues that signal to tissue damage. Studies using mice devoid of Ager (gene encoding RAGE) or pharmacological antagonists of RAGE are protective in animal models of diabetes mellitus, atherosclerosis, and high-fat diet–induced obesity, in least in part through key roles in monocytes/macrophages. RAGE signal transduction requires the interaction of RAGE cytoplasmic domain with the formin, DIAPH1 (diaphanous 1) and novel antagonists of this interaction show significant promise in attenuation of the maladaptive effects of RAGE ligands in cellular and in vivo models. Finally, this brief review discusses evidence for RAGE axis perturbation in human monocytes/macrophages and how tracing RAGE activity in these cells may identify target engagement biomarkers of RAGE antagonism for future clinical trials.Keywords
This publication has 68 references indexed in Scilit:
- Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signalingJournal of Experimental Medicine, 2012
- Formin mDia1 Mediates Vascular Remodeling via Integration of Oxidative and Signal Transduction PathwaysCirculation Research, 2012
- Signal Transduction in Receptor for Advanced Glycation End Products (RAGE)Journal of Biological Chemistry, 2012
- Opposing roles of RAGE and Myd88 signaling in extensive liver resectionThe FASEB Journal, 2011
- Elevated Serum Levels of Advanced Glycation End Products and their Monocyte Receptors in Patients with Type 2 DiabetesArchives of Medical Research, 2011
- Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetesClinical Science, 2010
- Aldose Reductase and AGE–RAGE pathways: central roles in the pathogenesis of vascular dysfunction in aging ratsAging Cell, 2010
- Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling and Up-regulation of Egr-1 in Hypoxic MacrophagesJournal of Biological Chemistry, 2010
- Formins in cell signalingBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42Journal of Biological Chemistry, 2008